Efficacy and safety of Dengyinnaotong Capsule in patients with Cognitive impairment caused by cerebral Small Vessel Disease: study protocol of a multicenter, randomized, open-label, controlled trial (De-CSVD trial)

Peer Review reports

Original Submission
8 Dec 2021	Submitted	Original manuscript
14 Mar 2022	Reviewed	Reviewer Report - Alexander Gough
13 Apr 2022	Reviewed	Reviewer Report - Caroline Fairhurst
9 May 2022	Author responded	Author comments - Yan-Xia Li
Resubmission - Version 2
9 May 2022	Submitted	Manuscript version 2
23 May 2022	Reviewed	Reviewer Report - Caroline Fairhurst
25 May 2022	Reviewed	Reviewer Report - Alexander Gough
31 May 2022	Author responded	Author comments - Yan-Xia Li
Resubmission - Version 3
31 May 2022	Submitted	Manuscript version 3
20 Jun 2022	Reviewed	Reviewer Report - Caroline Fairhurst
21 Jun 2022	Reviewed	Reviewer Report - Alexander Gough
3 Jul 2022	Author responded	Author comments - Yan-Xia Li
Resubmission - Version 4
3 Jul 2022	Submitted	Manuscript version 4
26 Jul 2022	Reviewed	Reviewer Report - Caroline Fairhurst
Resubmission - Version 5
	Submitted	Manuscript version 5
Publishing
7 Aug 2022	Editorially accepted
17 Aug 2022	Article published	10.1186/s13063-022-06646-6

Back to article page